Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229106 · ClinicalTrials.gov registry record · Phase 4
Symfony vs Vivity in Dim Light
A Phase 4 study of Cataract, sponsored by Carolina Eyecare Physicians.
- Completed
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT06229106: Completed Phase 4 study of Cataract, sponsored by Carolina Eyecare Physicians.
NCT06229106 is a Phase 4 study of Cataract that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 64 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06229106, a Phase 4 study of Cataract, has completed, sponsored by Carolina Eyecare Physicians.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the visual outcomes of the Symfony lens and the Vivity lens under mesopic lighting conditions in adult patients undergoing routine cataract surgery. Participants will be asked to read a visual acuity chart at different distances in dim light.
Primary Outcome
logMAR visual acuity
Conditions Studied
Interventions
- DEVICE Vivity IOL
- DEVICE Symfony IOL
Study Locations (2)
Florida
- Center for Sight - Sarasota
South Carolina
- Carolina Eyecare Physicians, LLC - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2024-10-30 |
| Phase | Phase 4 |
What the finished NCT06229106 record still lists
NCT06229106 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which Vivity IOL is the first listed.
NCT06229106 reports a single indexed study location in Florida, South Carolina.
Frequently Asked Questions
What is clinical trial NCT06229106 about?
NCT06229106 is a clinical study titled "Symfony vs Vivity in Dim Light". The purpose of this study is to evaluate the visual outcomes of the Symfony lens and the Vivity lens under mesopic lighting conditions in adult patients undergoing routine cataract surgery. Participants will be asked to read a visual acuity chart at different distances in dim light.
What is the current status of trial NCT06229106?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2023-12-01. Estimated completion is 2024-10-30.
What conditions does trial NCT06229106 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT06229106?
The interventions under investigation include: Vivity IOL (DEVICE), Symfony IOL (DEVICE).
Who is sponsoring clinical trial NCT06229106?
This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06229106 being conducted?
This trial has 2 study locations across Florida, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06229106's enrollment target sits among peer trials
64 52nd of 83 higher than 31 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI